title: Chemotherapy for skull base cancers.
abstract: This article focuses on treatment options for select skull base problems that have decreased post-treatment morbidity and, in many cases, improved survival. The select skull base cancers covered include nasopharyngeal carcinoma, squamous cell carcinoma of the paranasal sinuses, sinonasal undifferentiated carcinoma, neuroendocrine carcinoma, esthesioneuroblastoma, and salivary gland carcinoma.
authors.affiliation: Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. ediaz@mdanderson.org
authors.forename: E M
authors.initials: EM
authors.lastname: Diaz
authors.forename: M S
authors.initials: MS
authors.lastname: Kies
mesh_terms: D003528:Carcinoma, Adenoid Cystic / Q000188:drug therapy; D018278:Carcinoma, Neuroendocrine / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D018304:Esthesioneuroblastoma, Olfactory / Q000188:drug therapy; D006801:Humans; D010255:Paranasal Sinus Neoplasms / Q000188:drug therapy; D019292:Skull Base Neoplasms / Q000188:drug therapy*